2m 2m 2m 2m 2m 2m 2m
VIEMED HEALTHCRE (VMD)
NASDAQ
$9.56$0.00 (0.00%)
Price as of Jun 03, 2026 4:13 PM EDT- $376.7MMarket Cap
- 39.62%1-Year Change
- Medical DevicesIndustry
VIEMED HEALTHCRE (VMD)
$9.56$0.00 (0.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 270.3M +20.52% | 224.3M +22.54% | 183.0M +31.82% | 138.8M +18.60% | |
Cost of Revenue | 114.8M +26.10% | 91.1M +29.66% | 70.2M +29.68% | 54.2M +24.05% | |
Gross Profit | 155.5M +16.71% | 133.2M +18.11% | 112.8M +33.19% | 84.7M +15.35% | |
Sales and Marketing Expense | 121.4M +14.28% | 106.2M +20.84% | 87.9M +28.94% | 68.2M +24.17% | |
Research and Development Expense | -3.0M -1.66% | -3.1M +10.28% | -2.8M +3.19% | -2.7M +27.77% | |
Depreciation and Amortization Expense | 28.6M +12.79% | 25.4M +16.04% | 21.9M +39.87% | 15.6M +38.17% | |
Total Operating Expenses | 114.8M +26.10% | 91.1M +29.66% | 70.2M +29.68% | 54.2M +24.05% | |
Operating Profit | 22.9M +28.21% | 17.9M +24.91% | 14.3M +73.65% | 8.3M -28.74% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -1.2M +52.32% | -776,000 +83.02% | -424,000 +115.23% | -197,000 -38.05% | |
Interest Income and Expense and Net | -1.2M +52.32% | -776,000 +83.02% | -424,000 +115.23% | -197,000 -38.05% | |
Total Nonoperating Income and Expense | 252,000 +245.66% | -173,000 -276.53% | 98,000 -90.09% | 989,000 -39.03% | |
Income before Taxes | 21.8M +34.61% | 16.2M +12.36% | 14.4M +60.08% | 9.0M -28.10% | |
Income Taxes | 6.4M +34.24% | 4.8M +14.78% | 4.1M +49.86% | 2.8M -18.03% | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Net Income | 14.9M +32.57% | 11.3M +9.98% | 10.2M +64.63% | 6.2M -31.82% | |
Net Income from Continuing Operations Applicable to Common | 21.8M +34.61% | 16.2M +12.36% | 14.4M +60.08% | 9.0M -28.10% | |
Basic EPS and Net Income | 0.38 +31.03% | 0.29 +7.41% | 0.27 +68.75% | 0.16 -30.43% | |
Diluted EPS and Net Income | 0.37 +32.14% | 0.28 +12.00% | 0.25 +56.25% | 0.16 -27.27% | |
Basic Weighted Average Shares | 38.9M +0.36% | 38.8M +1.05% | 38.4M -0.78% | 38.7M -2.12% | |
Diluted Weighted Average Shares | 40.8M +0.05% | 40.8M +1.06% | 40.4M +1.44% | 39.8M -2.15% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 13.5M -23.03% | 17.5M +36.62% | 12.8M -24.09% | 16.9M -40.46% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 13.5M -23.03% | 17.5M +36.62% | 12.8M -24.09% | 16.9M -40.46% | |
Total Current Assets | 48.5M -8.30% | 52.9M +37.83% | 38.4M -3.46% | 39.7M -16.00% | |
Accumulated Depreciation | 60.9M +5.03% | 58.0M +9.57% | 52.9M +32.68% | 39.9M +42.22% | |
Property and Plant and Equipment and Net | 78.8M +3.27% | 76.3M +3.67% | 73.6M +7.51% | 68.4M +8.90% | |
Total Long-Term Assets | 150.7M +21.32% | 124.2M +6.57% | 116.5M +50.75% | 77.3M +9.41% | |
Total Assets | 199.2M +12.47% | 177.1M +14.32% | 154.9M +32.34% | 117.0M -0.78% | |
Income Taxes Payable | 0 -100.00% | 3.9M +80.35% | 2.2M N/A | N/A N/A | |
Total Short-Term Debt | 1.1M +166.50% | 409,000 -61.85% | 1.1M N/A | 0 -100.00% | |
Total Current Liabilities | 41.1M +9.99% | 37.3M +16.19% | 32.1M +70.32% | 18.9M +5.90% | |
Total Long-Term Debt | 11.3M +214.60% | 3.6M -40.20% | 6.0M N/A | 0 -100.00% | |
Total Long-Term Liabilities | 14.6M +126.28% | 6.4M -27.42% | 8.9M +715.81% | 1.1M -79.59% | |
Total Liabilities | 55.6M +27.11% | 43.8M +6.75% | 41.0M +105.52% | 19.9M -13.80% | |
Retained Earnings | 102.9M +14.72% | 89.7M +12.83% | 79.5M +13.81% | 69.8M -4.76% | |
Total Stockholders Equity | 141.5M +7.73% | 131.4M +15.36% | 113.9M +17.30% | 97.1M +2.40% | |
Total Shares Outstanding | 38.0M -2.85% | 39.1M +1.63% | 38.5M +1.20% | 38.0M -4.01% | |
Cash Flow | |||||
Cash from Operating Activities | 51.9M +32.81% | 39.1M -13.54% | 45.2M +62.94% | 27.7M +23.36% | |
Capital Expenditures | 40.0M +5.86% | 37.8M +44.76% | 26.1M +13.95% | 22.9M +15.98% | |
Cash from Investing Activities | -50.2M +63.41% | -30.7M -41.09% | -52.1M +117.35% | -24.0M +21.42% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -5.8M +56.93% | -3.7M -230.54% | 2.8M +118.51% | -15.3M +186.90% | |
Financials Ratio | |||||
Gross Margin | 57.52% -3.17% | 59.40% -3.62% | 61.63% +1.04% | 60.99% -2.74% | |
Operating Margin | 8.49% +6.38% | 7.98% +1.94% | 7.83% +31.74% | 5.94% -39.91% | |
Return on Assets | 7.94% +16.97% | 6.79% -9.91% | 7.53% +42.27% | 5.30% -33.12% | |
Return on Equity | 10.94% +19.14% | 9.19% -5.40% | 9.71% +49.74% | 6.48% -37.29% | |
Revenue Growth | 20.52% -8.95% | 22.54% -29.17% | 31.82% +71.10% | 18.60% +271.40% | |
Current Ratio | 1.18 -16.63% | 1.42 +18.62% | 1.19 -43.32% | 2.11 -20.67% | |
Cash Ratio | 0.33 -30.03% | 0.47 +17.56% | 0.40 -55.43% | 0.90 -43.77% | |
Debt-to-Equity Ratio | 0.09 +187.83% | 0.03 -51.05% | 0.06 N/A | 0.00 -100.00% | |
Debt-to-Assets Ratio | 0.06 +175.22% | 0.02 -50.55% | 0.05 N/A | 0.00 -100.00% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow